GSK’s Shingrix new prefilled syringe presentation accepted for review by European Medicines Agency
GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency (EMA) has accepted for review the regulatory application of a prefilled syringe presentation of Shingrix (GSK’s Recombinant ...
London: GSK plc has announced that the European Medicines Agency (EMA) has accepted for review the regulatory application of ...
GlobalData on MSN14h
GSK and University of Oxford partner for cancer vaccine researchGSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback